1 - 20 of 601 <<previous | next>>
| Newspapers Examine Pharmaceutical Companies' Influence On Physicians |
Newspapers on Wednesday examined issues related to the relationship between pharmaceutical companies and physicians. Summaries of the articles appear below. Gifts: Psychiatrists in Vermont earn more money from pharmaceutical companies than other medical specialists, according to a report released on Tuesday by the state, the
2007-06-29 16:00 |
| GPhA Statement On Sens. Kennedy-Enzi-Clinton-Hatch Biogenerics Legislation |
Generic Pharmaceutical Association (GPhA) President and CEO Kathleen Jaeger yesterday released the following statement regarding legislation crafted by Senators Edward Kennedy, Michael Enzi, Hillary Clinton, and Orrin Hatch that would authorize the Food and Drug Administration to
2007-06-29 03:00 |
| Kohl Examines Drug Industry Practice Of Providing Payments To Doctors, Influencing Prescribing Behaviors, USA |
Senate Special Committee on Aging Chairman Herb Kohl (D-WI) held a hearing to examine the pharmaceutical industry's costly practice of providing payments and gifts to doctors, and to consider what kind of influence this wields over some of our nation's physicians. It is estimated that drug companies spend 19 billion dollars annually on doctors in the form of lecture honoraria and conference registration fees, research grants, trips, meals, drug samples, and other freebies.
2007-06-29 03:00 |
| Prescription Drug Reimportation Opponents, Supporters Discuss Issue At PhRMA Briefing |
A congressional staff briefing on Monday by the Pharmaceutical Research and Manufacturers of America addressed drug reimportation "in anticipation that lawmakers will try to legalize low-cost drug purchases from abroad by attaching it to must-pass legislation," CongressDaily reports. At the briefing, titled "Know the Threat Behind Importation," Peter Pitts, president of the
2007-06-28 06:00 |
| Modified Mushrooms May Yield Human Drugs |
Mushrooms might serve as biofactories for the production of various beneficial human drugs, according to plant pathologists who have inserted new genes into mushrooms."There has always been a recognized potential of the mushroom as being a choice platform for the mass production of commercially valuable proteins," said Charles Peter Romaine, who holds the John B. Swayne Chair in spawn science and professor of plant pathology at Penn State.
2007-06-27 05:00 |
| House Committee Passes Prescription Drug User Fee Act Reauthorization Legislation |
The House Energy and Commerce Committee on Thursday voted 39-0 to approve nine bills that would expand FDA's authority to regulate prescription drug safety and increase user fees paid by drug and medical device companies, Dow Jones reports. The legislation would reauthorize the Prescription Drug User Fee Act, which expires Sept. 30.
2007-06-26 07:00 |
| Department Of Health, Goldshield Settlement, UK |
The Department of Health and Goldshield Group Plc, Goldshield Pharmaceuticals Ltd and Forley Generics Limited ("Goldshield") are pleased to jointly announce settlement of the claims brought against Goldshield for alleged anti-competitive cartel conduct in connection with the supply to the NHS of generic drugs.
2007-06-26 03:00 |
| Meeting Highlights From The Committee For Medicinal Products For Human Use, 18-21 June 2007, Europe Positive Opinions |
The European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has adopted eleven positive opinions, three of which relate to similar biological medicinal products, recommending the granting of a marketing authorisation for the following medicinal products: * Atriance (nelarabine), from Glaxo Group Limited, for the treatment of T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic leukaemia (T-LBL) of patients in second relapse.
2007-06-26 03:00 |
| Glide Pharma Is Overall Winner Of Prestigious 2007 Medical Futures Innovation Awards |
Glide Pharma, the specialty pharmaceutical company developing products based on its innovative needle-free drug delivery system, has won the Best Business Award at the 2007 Medical Futures Innovation Awards. The Awards are widely regarded as the healthcare industry's Oscars and this year's competition attracted a record number of over 500 entries. The Best Business Award is given to the overall winner from among the 25 award winners.
2007-06-26 03:00 |
| AMA Calls For Investigation Of Store-Based Health Clinics |
The American Medical Association (AMA) announced today that it would call for investigations into potential conflicts of interest posed by joint ventures between store-based health clinics and pharmacy chains. The AMA's call for investigations was driven by retailers who have stated that store-based health clinics help drive additional store traffic, which can increase sales of lucrative prescription drugs and other non-health related products.
2007-06-26 02:00 |
1 - 20 of 601 <<previous | next>>
|
